SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

H.C. Wainwright Maintains Buy on Immunomedics, Lowers Price Target to $54

H.C. Wainwright analyst Robert Burns maintains Immunomedics (NASDAQ:IMMU) with a Buy and lowers the price target from $60 to $54.

Benzinga · 05/07/2020 14:38

H.C. Wainwright analyst Robert Burns maintains Immunomedics (NASDAQ:IMMU) with a Buy and lowers the price target from $60 to $54.